Subcuject is a medical device company developing and commercializing an innovative and proprietary platform for subcutaneous Wearable Bolus Injection - the Subcuject WBI. The device platform applies osmosis as driving force, and offers a unique combination of low cost, friendliness for patients and design for pharma company drug integration as a combination product. Subcuject collaborates with Phillips-Medisize on development, manufacturing and commercialization of drug specific combination products